Depression and Anxiety Trial, Recruiting NCT07228520 Sponsor: Johns Hopkins University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07228520
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who report pain of more than 3 out of 10 that has lasted longer than 3 months and stops them from doing at least one activity they would like to do
  • People who live independently in the community (not in a care facility)
  • People who live in the Central Maryland area
  • People who score 5 or higher on a standard depression questionnaire (called the PHQ-9) on at least two separate occasions over a two-week period
  • People who are considered "pre-frail" (meeting one or two markers of physical frailty) or "frail" (meeting three or more markers of physical frailty), as measured by a standard frailty assessment (confirm with trial site)
  • People who have at least one limitation with either basic daily activities (such as bathing or dressing) or more complex daily tasks (such as managing finances or using transportation)

Who may not be able to join:

  • People who have been hospitalised more than 3 times in the past year
  • People who are currently receiving physical therapy
  • People who have been given a terminal diagnosis with an expected survival of less than one year
  • People with more than moderate intellectual or cognitive impairment, as measured by a standard short mental status questionnaire (confirm with trial site for specific scoring details)
  • People who are not able to speak or understand English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Janiece L Taylor, PhD, Johns Hopkins School of Nursing

Phone: 443-287-4503

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
30 November 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Pain Intensity as assessed by the Patient Reported Outcomes Measurement Information System (PROMIS); Change in Pain Interference as assessed by the PROMIS Pain Interference; Change in Depressive Symptoms as assessed by the Patient Health Questionnaire 9 (PHQ-9); Change in Depressive Symptoms as assessed by the PROMIS 57

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov